# Todd M. Tuttle

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/todd-m-tuttle/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,166 |
| Field | Breast Cancer Treatment Studies |
| h-index | 56 |
| i10-index | 143 |
| Last Known Institution | University of Minnesota |
| OpenAlex ID | https://openalex.org/A5015937592 |
| ORCID iD | 0000-0001-6603-2062 |
| Works | 428 |

## Researcher papers

- [Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend Toward More Aggressive Surgical Treatment](https://scholariq.org/papers/increasing-use-of-contralateral-prophylactic-mastectomy-for-breast-cancer/)
- [Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes](https://scholariq.org/papers/ductal-carcinoma-in-situ-of-the-breast-a-systematic-review-of-incidence/)
- [Sentinel Lymph Node Biopsy for Breast Cancer: A Suitable Alternative to Routine Axillary Dissection in Multi-Institutional Practice When Optimal Technique Is Used](https://scholariq.org/papers/sentinel-lymph-node-biopsy-for-breast-cancer-a-suitable-alternative-to-routine/)
- [Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement](https://scholariq.org/papers/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-in-the/)
- [Trends in the Treatment of Ductal Carcinoma In Situ of the Breast](https://scholariq.org/papers/trends-in-the-treatment-of-ductal-carcinoma-in-situ-of-the-breast/)
- [Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In Situ](https://scholariq.org/papers/increasing-rates-of-contralateral-prophylactic-mastectomy-among-patients-with/)
- [Trends in the incidence and treatment of parathyroid cancer in the United States](https://scholariq.org/papers/trends-in-the-incidence-and-treatment-of-parathyroid-cancer-in-the-united-states/)
- [Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo<sup>1</sup>H MR Spectroscopy—A Pilot Study at 4 T](https://scholariq.org/papers/neoadjuvant-chemotherapy-of-locally-advanced-breast-cancer-predicting-response/)
- [Dermal Injection of Radioactive Colloid Is Superior to Peritumoral Injection for Breast Cancer Sentinel Lymph Node Biopsy: Results of a Multiinstitutional Study](https://scholariq.org/papers/dermal-injection-of-radioactive-colloid-is-superior-to-peritumoral-injection-for/)
- [Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer](https://scholariq.org/papers/comparison-of-side-effects-between-sentinel-lymph-node-and-axillary-lymph-node/)
- [Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis](https://scholariq.org/papers/travel-treatment-choice-and-survival-among-breast-cancer-patients-a-population/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Implant and Reconstruction](https://scholariq.org/topics/breast-implant-and-reconstruction/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)

## Researcher university

- [University of Minnesota](https://scholariq.org/institutions/university-of-minnesota/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.